Biofrontera AG buy melinda
Start price
05.03.18
/
50%
€5.95
Target price
09.03.18
€6.40
Performance (%)
8.07%
End price
09.03.18
€6.43
Summary
This prediction ended on 09.03.18 with a price of €6.43. The BUY prediction by melinda finished with a performance of 8.07%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biofrontera AG | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to melinda what are the pros and cons of Biofrontera AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Biofrontera AG diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Kalender 11/07 Generalversammlung
Biofrontera: Die Europäische Kommission genehmigt die Verwendung von Ameluz in Kombination mit der photodynamischen Therapie Tageslicht
5. März (Reuters) - Die Biofrontera AG :: PTA-ADHOC: Biofrontera AG: DIE EUROPÄISCHE KOMMISSION GENEHMIGT DEN EINSATZ IN KOMBINATION MIT Ameluz THERAPY Photodynamischen den Tag.
Stopped prediction by melinda for Biofrontera AG
Biofrontera AG
Start price
Target price
Perf. (%)
€1.60
06.12.21
06.12.21
€2.80
06.12.22
06.12.22
-1.25%
07.12.22
07.12.22
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€3.16
17.03.20
17.03.20
€6.00
04.11.21
04.11.21
-25.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Biofrontera AG
Start price
Target price
Perf. (%)
€6.29
09.03.18
09.03.18
€8.00
14.03.18
14.03.18
13.99%
14.03.18
14.03.18
Could be worthwhile Investment >10% per year